Evidence map›Paper›PMID 29342249›Full record

ArticleBioinformatics (Oxford, England)2018

Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer.

Bahman Afsari, Theresa Guo, Michael Considine, Liliana Florea, Luciane T Kagohara, Genevieve L Stein-O'Brien, Dylan Kelley, Emily Flam, Kristina D Zambo, Patrick K Ha and 6 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Quantifying transcriptome diversity: a review.Briefings in functional genomics · 2024
    Review
  3. Article
  4. Article
  5. Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Bahman AfsariDivision of Biostatistics and Bioinformatics, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center.
Theresa GuoDepartment of Otolaryngology-Head and Neck Surgery.
Michael ConsidineDivision of Biostatistics and Bioinformatics, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center.
Liliana FloreaMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
Luciane T KagoharaDivision of Biostatistics and Bioinformatics, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center.
Genevieve L Stein-O'BrienDivision of Biostatistics and Bioinformatics, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center.
Dylan KelleyDepartment of Otolaryngology-Head and Neck Surgery.
Emily FlamDepartment of Otolaryngology-Head and Neck Surgery.
Kristina D ZamboDepartment of Otolaryngology-Head and Neck Surgery.
Patrick K HaDepartment of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, CA 94158, USA.
Donald GemanDepartment of Applied Mathematics & Statistics, Johns Hopkins University, Baltimore, MD 21218, USA.
Michael F OchsDepartment of Mathematics & Statistics, The College of New Jersey, Ewing, NJ 08628, USA.
Joseph A CalifanoDivision of Otolaryngology, Department of Surgery, University of California, San Diego, CA 92093, USA.
Daria A GaykalovaDepartment of Otolaryngology-Head and Neck Surgery.
Alexander V FavorovDivision of Biostatistics and Bioinformatics, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center.
Elana J FertigDivision of Biostatistics and Bioinformatics, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center.

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
TUMOR SUPPRESOR GENE PROMOTER HYPERMETHYLATION FOR DETECTION OF HEAD AND NECKP50DE019032 · NIDCR · JOHNS HOPKINS UNIVERSITY · PI SIDRANSKY, DAVID · 2007 to 2016
$27.1M
RESEARCH TRAINING IN OTOLARYNGOLOGYT32DC000027 · NIDCD · JOHNS HOPKINS UNIVERSITY · PI CAREY, JOHN PATRICK · 1989 to 2023
$5.5M
Epigenetic Biomarker Discovery in HPV Related HNSCCR01DE023347 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CALIFANO, JOSEPH A · 2013 to 2017
$1.9M
Dynamical Models of Cetuximab Resistance in HNSCC Based on Serial Genomics DataR01CA177669 · NCI · JOHNS HOPKINS UNIVERSITY · PI FERTIG, ELANA · 2014 to 2019
$1.8M
Integrated pathway analysis of altered driver genes in adenoid cystic carcinomaR01DE023227 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HA, PATRICK KYONGMIN · 2012 to 2015
$1.6M
Modeling Transcriptional Reprogramming by Markov Chain Monte Carlo SamplingR01LM011000 · NLM · JOHNS HOPKINS UNIVERSITY · PI OCHS, MICHAEL F · 2012 to 2014
$886k
Characterizing genome-wide alternative splicing in HPV related HNSCCR21DE025398 · NIDCR · JOHNS HOPKINS UNIVERSITY · PI GAYKALOVA, DARIA A · 2015 to 2016
$446k
NCI NIH HHS P30 CA006973NCI NIH HHS R01 CA177669NIDCD NIH HHS T32 DC000027NIDCR NIH HHS P50 DE019032NIDCR NIH HHS R01 DE023227NIDCR NIH HHS R01 DE023347NIDCR NIH HHS R21 DE025398NLM NIH HHS R01 LM011000
6 · The paper itself

Abstract

Motivation: Current bioinformatics methods to detect changes in gene isoform usage in distinct phenotypes compare the relative expected isoform usage in phenotypes. These statistics model differences in isoform usage in normal tissues, which have stable regulation of gene splicing. Pathological conditions, such as cancer, can have broken regulation of splicing that increases the heterogeneity of the expression of splice variants. Inferring events with such differential heterogeneity in gene isoform usage requires new statistical approaches. Results: We introduce Splice Expression Variability Analysis (SEVA) to model increased heterogeneity of splice variant usage between conditions (e.g. tumor and normal samples). SEVA uses a rank-based multivariate statistic that compares the variability of junction expression profiles within one condition to the variability within another. Simulated data show that SEVA is unique in modeling heterogeneity of gene isoform usage, and benchmark SEVA's performance against EBSeq, DiffSplice and rMATS that model differential isoform usage instead of heterogeneity. We confirm the accuracy of SEVA in identifying known splice variants in head and neck cancer and perform cross-study validation of novel splice variants. A novel comparison of splice variant heterogeneity between subtypes of head and neck cancer demonstrated unanticipated similarity between the heterogeneity of gene isoform usage in HPV-positive and HPV-negative subtypes and anticipated increased heterogeneity among HPV-negative samples with mutations in genes that regulate the splice variant machinery. These results show that SEVA accurately models differential heterogeneity of gene isoform usage from RNA-seq data. Availability and implementation: SEVA is implemented in the R/Bioconductor package GSReg. Contact: bahman@jhu.edu or favorov@sensi.org or ejfertig@jhmi.edu. Supplementary information: Supplementary data are available at Bioinformatics online.

Indexed as

Alternative SplicingSoftwareComputational BiologyGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansModels, GeneticNeoplasmsProtein IsoformsSequence Analysis, RNAProtein Isoforms

Identifiers

PMID29342249
PMCPMC5972655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.